Seeking Alpha


Send Message
View as an RSS Feed
View Qniform's Comments BY TICKER:
Latest  |  Highest rated
  • Cimatron: CAD/CAM Software Company At A Bargain Price [View instapost]
    It is just an incremental feature. Sandvik (the Adveon owner) is only a $12 billion company and I don't know how big a deal Adveon is.
    As you said, it is the larger value proposition that makes CIMT a interesting investment.
    Jul 31 01:14 PM | Likes Like |Link to Comment
  • A Look At Noble's Current Industry Position And Its Forward Prospects [View article]
    Thanks for the overview. One caution I'd offer is that backlog is not the guaranteed revenue you seem to believe it is. Contracts may be cancelled, sometimes without much more than notice required. Simply do an internet search under "drilling contract cancelled" and you'll find numerous examples (including some for Noble). I'm sure Noble carried internal revenue projections with a decreasing multiplier the farther into the future it is supposed to be recognized. The only 100% certain revenue is that which is deposited in the bank.
    Jul 30 04:24 PM | 1 Like Like |Link to Comment
  • Will The Lobster Deal Be A Tipping Point For This Net Lease REIT? [View article]
    As an investor who bought during the carnage after the secondary offering I can't complain. I've exited half of the common position I held at a better than 12% gain in a month (I still hold a bigger position in the preferred). The larger concern is how to trust management statements when they clearly stated that such an offering was not going to happen. Investors in this space (and in MLPs as well) should expect secondaries and debt issuance as part of how growth occurs, and management should be clear about the metrics under which they will happen.

    It will be better if management gives that guidance or even just says nothing to influence expectations about the process.
    Jul 30 01:57 PM | 5 Likes Like |Link to Comment
  • I'm Happy To See This Healthcare REIT Spreading The Love [View article]
    I hold HTA for the secular growth story and as a potential bolt on acquisition for one of the big diversified healthcare REITs. So far, I like everything they're doing - except how much the CEO earns.

    I think the chart of the dividend increase makes it look too good visually. After all, it's only .8%. Not that great and right out of the Realty Income play book - a token increase just to say there was one.
    Jul 30 01:47 PM | 3 Likes Like |Link to Comment
  • Where Are The Digital Shorts Now? [View article]
    I'm also long but I can share with you that it is fairly common to cover a day or two before the ex date and resell again if/when there is a significant dividend . This doesn't show up in any short interest report I've seen, but you can sometimes see it on the charts.
    Jul 30 10:25 AM | Likes Like |Link to Comment
  • Cimatron: CAD/CAM Software Company At A Bargain Price [View instapost]
    More features -
    Jul 29 12:16 PM | Likes Like |Link to Comment
  • Where Are The Digital Shorts Now? [View article]
    Right jerryki. It's a good policy not to feed trolls. Nonsensical comments are best ignored
    Jul 27 10:59 PM | 1 Like Like |Link to Comment
  • Vale's Turnaround Is A Pipe Dream [View article]
    That would not be an apt usage either. After all the idea of hot or dry doesn't really fit a businesses' prospects any more than a romantic usage.

    It was groping for a 3rd definition - troubled or distressed. It's just never used that way.
    Jul 23 10:06 AM | Likes Like |Link to Comment
  • Vale's Turnaround Is A Pipe Dream [View article]
    "a torrid condition"

    Excuse me, but you should not rely on a thesaurus for definitions. This usage is almost unknown.
    Jul 21 10:26 PM | Likes Like |Link to Comment
  • Short Gilead: Sentiment Is Too Positive Ahead Of Q2 Earnings [View instapost]
    Could be a good trade, but remember the saying about how long the market can stay irrational. Certainly longer than I could stay short.
    Jul 21 10:22 PM | Likes Like |Link to Comment
  • Zacks' Bull Of The Day: Intel [View article]
    jbrunnr7, I like that you are a customer of a couple of my big positions - INTC and DLR. I'll be sure to recommend you for hosting, etc.
    Jul 21 07:01 PM | 1 Like Like |Link to Comment
  • American Realty Capital Properties: High Yield And High Risk [View article]
    "which entitled the CEO to quite a handsome compensation package, provided that the shares return at least 7%/year. Given the fact that current yield is at 8%, this meant that the goal of management was to extract money from the business for their own gain, rather than work for the benefit of shareholders."

    Um, yield is not what the compensation metric is. It's total return.

    If American Realty achieves a total return of more than 7% a year, the plan pays out 4% of the dollar amount of the total return that exceeds that hurdle. Total return is a measure of shareholder gains based on market performance and dividends.
    Jul 21 02:52 PM | 5 Likes Like |Link to Comment
  • Gilead: 50% Upside From Here [View article]
    <I don't know when you sold the puts>

    <...however it seems like you probably aren't making that much on them.>

    Stating an obvious truth and concluding something on an admitted lack of data (let alone simply disregarding what I said about the subject).

    Not much point to the conversation, is there? Good luck.
    Jul 21 02:41 PM | 1 Like Like |Link to Comment
  • Gilead: 50% Upside From Here [View article]
    6228371 - my point is based on the entirely speculative nature of the author's conclusion (based on a seemingly whacky number from Nomura). Besides, since the sector already trades at ~17.5 multiple, a price expansion wouldn't change my point - it would simply expand it to include other players.

    I am well aware that selling puts is different than being long the stock. Isn't that what I said? That's why I specified how I am long. It simply means that I like GILD at the right price. All of my puts are/have had strikes below $75. I'm averaging around 20% annualized on those cash covered positions.
    Jul 20 07:45 PM | Likes Like |Link to Comment
  • Gilead: 50% Upside From Here [View article]
    The growth that is implicit in Nomura's numbers is suspect. Sovaldi at $22 billion? Really? (That's more than 260,000 full price treatments in one year). To put it into perspective, the highest revenue drug of all time - Lipitor - had peak sales of $13.7 billion. Are we to believe that Hep C is a more widespread problem than high cholesterol? By comparison, Credit Suisse, who is very bullish on GILD, models peak revenue of $13.2 billion in 2017.

    I like GILD, but folks lets be real. 50% upside from here puts market cap equal to Pfizer - tied for the #2 spot by market cap behind JNJ. Ahead of Roche. Ahead of Novartis. Ahead of several companies with much deeper product lists and pipelines.

    I'm making a lot of money on GILD by not owning it. I'm certainly not going to chase this one.

    Disclosure: long GILD via short puts.
    Jul 20 06:28 PM | 2 Likes Like |Link to Comment